Cours IMV Inc. Toronto S.E.
Actions
IMV
CA44974L3011
Recherche biotechnologique et médicale
CA 2021 | - | CA 2022 | - | Capitalisation | 30,6 M 41,83 M 27,95 M |
---|---|---|---|---|---|
Résultat net 2021 | -36 M -49,21 M -32,88 M | Résultat net 2022 | -38 M -51,94 M -34,71 M | VE / CA 2021 | - |
Trésorerie nette 2021 | 18,96 M 25,92 M 17,32 M | Dette nette 2022 | 7,67 M 10,49 M 7,01 M | VE / CA 2022 | - |
PER 2021 |
-2,47
x | PER 2022 |
-0,53
x | Employés | 63 |
Rendement 2021 * |
-
| Rendement 2022 |
-
| Flottant | 99,93% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Andrew Hall
CEO | Chief Executive Officer | - | 10/11/20 |
Brittany Davison
DFI | Director of Finance/CFO | - | - |
Chief Operating Officer | - | - |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Chairman | 58 | 01/07/20 | |
Kyle Kuvalanka
BRD | Director/Board Member | 56 | 01/04/21 |
Markus Warmuth
BRD | Director/Board Member | 53 | 06/11/18 |
Varia. 1 janv. | Capi. | |
---|---|---|
+1,51% | 42,75 Md | |
+49,22% | 41,61 Md | |
+8,57% | 41,34 Md | |
-12,36% | 26,59 Md | |
+8,92% | 25,49 Md | |
-25,13% | 18,12 Md | |
+29,17% | 12,24 Md | |
-3,12% | 11,76 Md | |
+6,35% | 11 Md |